We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRV icon
276
Travelers Companies
TRV
$80.2B
$91.5M 0.06%
450,002
-12,436
-3% -$2.67M
APP icon
277
Applovin
APP
$116B
$90.2M 0.06%
1,083,866
-461,971
-30% -$35.8M
SRE icon
278
Sempra
SRE
$54.8B
$89.8M 0.06%
1,180,886
+209,158
+22% +$15.5M
CHRW icon
279
C.H. Robinson
CHRW
$17.5B
$89.7M 0.06%
1,017,850
-19,405
-2% -$1.55M
BP icon
280
BP
BP
$107B
$89.4M 0.06%
2,477,708
+131,314
+6% +$4.92M
BSX icon
281
Boston Scientific
BSX
$71.5B
$88.7M 0.06%
1,152,055
-12,648
-1% -$926K
IWO icon
282
iShares Russell 2000 Growth ETF
IWO
$15B
$88.1M 0.06%
335,550
+24,278
+8% +$6.3M
KMI icon
283
Kinder Morgan
KMI
$68.7B
$87.4M 0.06%
4,397,883
+158,435
+4% +$3.02M
HBAN icon
284
Huntington Bancshares
HBAN
$35.5B
$87.3M 0.06%
6,626,615
-776,688
-10% -$10.4M
LYB icon
285
LyondellBasell Industries
LYB
$19.2B
$87M 0.06%
909,144
+49,190
+6% +$4.88M
LRCX icon
286
Lam Research
LRCX
$390B
$86.6M 0.06%
813,340
-445,810
-35% -$42.8M
D icon
287
Dominion Energy
D
$59.3B
$86.6M 0.06%
1,766,365
-63,632
-3% -$3.24M
NOBL icon
288
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$86.3M 0.06%
1,796,260
+588,372
+49% +$28.8M
BRK.A icon
289
Berkshire Hathaway Class A
BRK.A
$1.12T
$86.3M 0.06%
141
+5
+4% +$3.08M
OKE icon
290
Oneok
OKE
$54.5B
$85.1M 0.06%
1,043,515
-35,078
-3% -$2.8M
CTAS icon
291
Cintas
CTAS
$81.3B
$83.6M 0.05%
477,636
+26,444
+6% +$4.52M
TDG icon
292
TransDigm Group
TDG
$67.7B
$83.4M 0.05%
65,310
-218
-0.3% -$280K
PH icon
293
Parker-Hannifin
PH
$135B
$82.8M 0.05%
163,626
-10,322
-6% -$5.54M
CASY icon
294
Casey's General Stores
CASY
$30.9B
$81.4M 0.05%
213,292
-2,908
-1% -$970K
ADSK icon
295
Autodesk
ADSK
$52.6B
$80.6M 0.05%
325,864
-84,102
-21% -$18.9M
WEC icon
296
WEC Energy
WEC
$35.1B
$80M 0.05%
1,019,340
+23,827
+2% +$1.94M
IUSG icon
297
iShares Core S&P US Growth ETF
IUSG
$33.9B
$79.6M 0.05%
624,519
-6,030
-1% -$719K
BR icon
298
Broadridge
BR
$19B
$79.6M 0.05%
404,049
+5,256
+1% +$1.04M
MCHP icon
299
Microchip Technology
MCHP
$46B
$79.5M 0.05%
869,033
+14,557
+2% +$1.33M
INDA icon
300
iShares MSCI India ETF
INDA
$6.63B
$78.5M 0.05%
1,407,867
+343,115
+32% +$18.2M

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.